Literature DB >> 7804904

Construction of composite transposons for halophilic Archaea.

M L Dyall-Smith1, W F Doolittle.   

Abstract

Transposons with selectable marker genes (e.g., antibiotic resistance) have been extremely useful tools in bacterial genetics but have not been found naturally in Archaea. We constructed synthetic transposons consisting of halobacterial ISH elements (ISH2, ISH26, or ISH28) flanking a mevinolin resistance determinant. Introduction of these constructs into Haloferax volcanii cells can produce drug-resistant transformants through homologous recombination between the plasmid hmgA gene and the chromosomal hmgA locus. This problem was overcome by using another host, Haloarcula hispanica, the hmgA gene of which shares little homology with that from Haloferax volcanii. Introduction of an ISH28-based transposon (ThD28) into Haloarcula hispanica cells produced numerous transformants. Each of these was shown to contain an ISH-flanked mevinolin resistance determinant integrated into the cellular DNA. Integration was not obviously site specific. Transposon ThD26 (based on ISH26a), was less mobile, relative to ThD28, and the ISH2-based construct (ThD22) did not transpose at all in these cells. The further development of halobacterial transposons may provide useful genetic tools allowing rapid isolation and analysis of halobacterial genes, particularly those with no selectable phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804904     DOI: 10.1139/m94-148

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  10 in total

1.  An improved transposon for the halophilic archaeon Haloarcula hispanica.

Authors:  W G Woods; K Ngui; M L Dyall-Smith
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

2.  Ferredoxin-dependent glutamate synthase: involvement in ammonium assimilation in Haloferax mediterranei.

Authors:  C Pire; R M Martínez-Espinosa; F Pérez-Pomares; J Esclapez; M J Bonete
Journal:  Extremophiles       Date:  2013-11-30       Impact factor: 2.395

3.  Gene cloning, heterologous overexpression and optimized refolding of the NAD-glutamate dehydrogenase from Haloferax mediterranei.

Authors:  Susana Díaz; Francisco Pérez-Pomares; Carmen Pire; Juan Ferrer; María-José Bonete
Journal:  Extremophiles       Date:  2005-10-01       Impact factor: 2.395

4.  Halophage HF2: genome organization and replication strategy.

Authors:  S D Nuttall; M L Dyall-Smith
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  In vivo transposon mutagenesis of the methanogenic archaeon Methanosarcina acetivorans C2A using a modified version of the insect mariner-family transposable element Himar1.

Authors:  J K Zhang; M A Pritchett; D J Lampe; H M Robertson; W W Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

6.  Transposon Insertion Mutagenesis in Hyperthermophilic Crenarchaeon Sulfolobus islandicus.

Authors:  Changyi Zhang; Rachel J Whitaker
Journal:  Methods Mol Biol       Date:  2022

7.  His1, an archaeal virus of the Fuselloviridae family that infects Haloarcula hispanica.

Authors:  C Bath; M L Dyall-Smith
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Functional genomic and advanced genetic studies reveal novel insights into the metabolism, regulation, and biology of Haloferax volcanii.

Authors:  Jörg Soppa
Journal:  Archaea       Date:  2011-11-30       Impact factor: 3.273

9.  Random mutagenesis of the hyperthermophilic archaeon Pyrococcus furiosus using in vitro mariner transposition and natural transformation.

Authors:  Natalia Guschinskaya; Romain Brunel; Maxime Tourte; Gina L Lipscomb; Michael W W Adams; Philippe Oger; Xavier Charpentier
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Generation of comprehensive transposon insertion mutant library for the model archaeon, Haloferax volcanii, and its use for gene discovery.

Authors:  Saija Kiljunen; Maria I Pajunen; Kieran Dilks; Stefanie Storf; Mechthild Pohlschroder; Harri Savilahti
Journal:  BMC Biol       Date:  2014-12-09       Impact factor: 7.431

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.